Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15051-15100 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03955978
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
PHASE1
Active, not recruiting
10 participants
Started: Oct 15, 2019 · Completed: Dec 18, 2025
2 conditions
2 sponsors
1 location
NCT04084548
Perioperative Lidocaine and Ketamine in Abdominal Surgery
PHASE3
Active, not recruiting
420 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04165694
Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
NA
Active, not recruiting
54 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT04116437
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
PHASE2
Active, not recruiting
90 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2025
4 conditions
1 sponsor
24 locations
NCT03636243
Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery
NA
Active, not recruiting
37 participants
Started: Oct 15, 2019 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT03860792
Therapeutic Diets in Alzheimer's Disease
NA
Active, not recruiting
80 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04040764
Uncemented Tritanium TKR vs Cemented Triathlon TKR
NA
Active, not recruiting
60 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04070703
Tai Ji Quan and Cognitive Function in Older Adults With Mild Cognitive Impairment
NA
Active, not recruiting
318 participants
Started: Oct 15, 2019 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT03964727
Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
PHASE2
Active, not recruiting
227 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
65 locations
NCT04017468
Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion
PHASE2
Active, not recruiting
450 participants
Started: Oct 15, 2019 · Completed: Mar 31, 2027
1 condition
2 sponsors
7 locations
NCT04391114
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
NA
Active, not recruiting
107 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03970603
Syndesmosis Ankle Study
NA
Active, not recruiting
40 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT03914547
Home Video-based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children
NA
Active, not recruiting
396 participants
Started: Oct 15, 2019 · Completed: Mar 31, 2026
1 condition
4 sponsors
2 locations
NCT04630431
Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients
NA
Active, not recruiting
590 participants
Started: Oct 15, 2019 · Completed: Oct 15, 2026
2 conditions
1 sponsor
3 locations
NCT03983993
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
26 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2025
6 conditions
4 sponsors
3 locations
NCT03956537
PMCF Neo Pedicle Screw and Cage Systems
N/A
Active, not recruiting
150 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2028
6 conditions
2 sponsors
2 locations
NCT04281134
Development of Adaptive Deep Brain Stimulation for OCD
NA
Active, not recruiting
3 participants
Started: Oct 11, 2019 · Completed: Jun 30, 2026
1 condition
6 sponsors
3 locations
NCT03917238
Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
NA
Active, not recruiting
14 participants
Started: Oct 11, 2019 · Completed: Dec 25, 2026
1 condition
1 sponsor
2 locations
NCT04049513
ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
PHASE1
Active, not recruiting
30 participants
Started: Oct 11, 2019 · Completed: Mar 31, 2029
6 conditions
2 sponsors
1 location
NCT03863184
Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
PHASE2
Active, not recruiting
37 participants
Started: Oct 11, 2019 · Completed: Sep 30, 2027
1 condition
3 sponsors
1 location
NCT04126005
Natural History Study of Patients With Canavan Disease (CANinform Study)
N/A
Active, not recruiting
70 participants
Started: Oct 10, 2019 · Completed: Jul 31, 2025
1 condition
1 sponsor
3 locations
NCT03896646
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
NA
Active, not recruiting
42 participants
Started: Oct 10, 2019 · Completed: Sep 30, 2026
7 conditions
2 sponsors
1 location
NCT03910075
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)
PHASE3
Active, not recruiting
216 participants
Started: Oct 10, 2019 · Completed: May 1, 2026
2 conditions
6 sponsors
15 locations
NCT03961854
Lactobacillus Johnsonii in Children and Adolescents With T1D
PHASE2
Active, not recruiting
30 participants
Started: Oct 10, 2019 · Completed: Mar 11, 2026
1 condition
2 sponsors
1 location
NCT03934840
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
PHASE2
Active, not recruiting
22 participants
Started: Oct 10, 2019 · Completed: May 31, 2025
1 condition
1 sponsor
8 locations
NCT03952585
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
PHASE2/PHASE3
Active, not recruiting
384 participants
Started: Oct 9, 2019 · Completed: Dec 11, 2025
8 conditions
2 sponsors
494 locations
NCT04153539
Acute Health Effects of Traffic-Related Air Pollution Exposure
NA
Active, not recruiting
69 participants
Started: Oct 9, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03730649
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
EARLY_PHASE1
Active, not recruiting
12 participants
Started: Oct 9, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT04048941
One Needle Hand Acupuncture for MSK Disorders
NA
Active, not recruiting
120 participants
Started: Oct 8, 2019 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT04083430
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
PHASE4
Active, not recruiting
60 participants
Started: Oct 8, 2019 · Completed: Dec 15, 2025
3 conditions
1 sponsor
1 location
NCT04050436
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
PHASE2
Active, not recruiting
231 participants
Started: Oct 8, 2019 · Completed: Sep 30, 2025
3 conditions
2 sponsors
56 locations
NCT04602091
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
N/A
Active, not recruiting
2,300 participants
Started: Oct 8, 2019 · Completed: Jun 30, 2030
4 conditions
2 sponsors
60 locations
NCT03953300
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
PHASE4
Active, not recruiting
74 participants
Started: Oct 8, 2019 · Completed: Sep 9, 2026
1 condition
1 sponsor
35 locations
NCT04037254
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
PHASE1/PHASE2
Active, not recruiting
22 participants
Started: Oct 8, 2019 · Completed: Sep 26, 2025
7 conditions
2 sponsors
95 locations
NCT03833440
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
PHASE2
Active, not recruiting
114 participants
Started: Oct 8, 2019 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
N/A
Active, not recruiting
1,200 participants
Started: Oct 8, 2019 · Completed: Jun 27, 2026
8 conditions
15 sponsors
1 location
NCT04131166
Precision Nutrition and Metabolic Function
NA
Active, not recruiting
300 participants
Started: Oct 8, 2019 · Completed: Dec 31, 2029
2 conditions
2 sponsors
1 location
NCT03474692
Virta Health Registry
N/A
Active, not recruiting
50,000 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2039
5 conditions
1 sponsor
1 location
NCT03892655
Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
N/A
Active, not recruiting
170 participants
Started: Oct 7, 2019 · Completed: Jul 31, 2028
1 condition
1 sponsor
22 locations
NCT03910972
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
PHASE1/PHASE2
Active, not recruiting
290 participants
Started: Oct 7, 2019 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT04126200
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE2
Active, not recruiting
209 participants
Started: Oct 7, 2019 · Completed: Feb 12, 2029
1 condition
1 sponsor
40 locations
NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Oct 7, 2019 · Completed: Jun 7, 2022
8 conditions
1 sponsor
5 locations
NCT03983512
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NA
Active, not recruiting
58 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
4 conditions
2 sponsors
11 locations
NCT04016246
Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.
PHASE3
Active, not recruiting
233 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
13 locations
NCT03529422
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
PHASE2
Active, not recruiting
18 participants
Started: Oct 7, 2019 · Completed: May 6, 2026
4 conditions
2 sponsors
3 locations
NCT03962166
Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
N/A
Active, not recruiting
353 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04100200
Berries, Inflammation, and Gut Microbiome
NA
Active, not recruiting
105 participants
Started: Oct 7, 2019 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT04082897
ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation
PHASE2
Active, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
17 locations
NCT04007029
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
PHASE1
Active, not recruiting
24 participants
Started: Oct 4, 2019 · Completed: Aug 1, 2027
14 conditions
2 sponsors
1 location
NCT04236882
Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans
NA
Active, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Apr 30, 2030
2 conditions
2 sponsors
2 locations
Previous
1
More pages
299
300
301
302
303
304
305
More pages
431
Next